Press release
Investigation announced for Investors in shares of Geron Corporation (NASDAQ: GERN)
An investigation for investors in Geron Corporation (NASDAQ: GERN) shares over potential securities laws violations by Geron.
Investors who purchased shares of Geron Corporation (NASDAQ: GERN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Geron Corporation (NASDAQ: GERN) concerning whether a series of statements by Geron Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Menlo Park, CA based Geron Corporation, a clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. Geron Corporation was developing imetelstat in partnership with Janssen Biotech Inc. ("Janssen"), a division of Johnson & Johnson. Imetelstat was intended to treat certain cancers that occur in bone marrow and the IMbark study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.
On September 27, 2018, Geron Corporation announced that patients in the IMbark study had shown only 10% spleen response rate and 32% symptom response rate. Geron Corporation also announced that Janssen had terminated its partnership with the Geron for the development of imetelstat.
Shares of Geron Corporation (NASDAQ: GERN) declined from $6.23 per share on September 4, 2018 to as low as $0.95 per share in December 2018.
Those who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Geron Corporation (NASDAQ: GERN) here
News-ID: 1860917 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for Investors who lost money with shares of Spirit Aviation Holdin …
An investor, who purchased shares of Spirit Aviation Holdings, Inc. (OTC: FLYYQ), filed a lawsuit over alleged violations of Federal Securities Laws by Spirit Aviation Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Spirit Aviation Holdings, Inc. (OTC: FLYYQ) between May 28, 2025 and August 29, 2025, have certain options and for certain investors are short and strict deadlines…
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
More Releases for Geron
Geron Corporation (NASDAQ: GERN) Investor Alert: Deadline in Lawsuit on May 12, …
A deadline is coming up on May 12, 2025 in the lawsuit filed for certain investors of Geron Corporation (NASDAQ: GERN) over alleged securities laws violations by Geron Corporation.
Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and there are strict and short deadlines running. Deadline: May 12, 2025. Geron Corporation (NASDAQ: GERN) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According…
Lawsuit filed for Investors who lost money with shares of Geron Corporation (NAS …
An investor, who purchased shares of Geron Corporation (NASDAQ: GERN), filed a lawsuit over alleged violations of Federal Securities Laws by Geron Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and for certain investors are short and strict deadlines running. Deadline: May 12, 2025. NASDAQ: GERN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Stem Cell Therapy Market is Going to Boom | Geron Corp., Pluristem Therapeutics, …
Advance Market Analytics published a new research publication on "Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world.
Get inside Scoop of the…
Embryonic Stem Cell Market to see Huge Growth by 2025 | BioTime, Caladrius Biosc …
Latest released the research study on Global Embryonic Stem Cell Market, offers a detailed overview of the factors influencing the global business scope. Embryonic Stem Cell Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Embryonic Stem Cell Market. The study covers emerging…
Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GE …
An investigation was announced for current long-term investors in shares of Geron Corporation (NASDAQ: GERN) concerning potential breaches of fiduciary duties by certain directors and officers of Geron Corporation.
Investors who are current long term investors in Geron Corporation (NASDAQ: GERN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors in shares of Geron Corporation (NASDAQ: GERN)
An investor, who purchased shares of Geron Corporation (NASDAQ: GERN), filed a lawsuit over alleged violations of Federal Securities Laws by Geron Corporation.
Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and for certain investors are short and strict deadlines running. Deadline: March 23, 2020. NASDAQ: GERN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Geron Corporation was developing imetelstat in partnership…
